Please assess the completion status of the following clinical trial:

Trial Title: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have a history of and current complaint of CLDE.~* Use properly fitted daily-wear soft contact lenses.~* Able to wear contact lenses for at least 8 hours a day.~* If female, are non-pregnant or non-lactating.~Exclusion Criteria:~* Have changed brand of contact lens or care solutions within one month prior to Visit 1.~* Use extended (overnight) wear contact lenses.~* Have a clinically significant ophthalmic abnormality.~* Have had cauterization of the punctum or have had punctal plugs (silicone or collagen) inserted or removed within the 90 days prior to the screening.~* Have any active ongoing ocular infection or ocular disease.~* Have a serious medical condition which could confound study assessments.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- azithromycin ophthalmic solution, 1% (Type: EXPERIMENTAL): None
- rewetting drops (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).